House Bill 882
2021-2022 Regular Session
An Act amending the act of November 21, 2016 (P.L.1318, No.169), known as the Pharmacy Audit Integrity and Transparency Act, in pharmacy benefit manager cost transparency requirements, providing for s . . .haring of cost, benefit and coverage data required.
Co-Sponsorship Memo
Prime Sponsor
Representative Valerie Gaydos
R House District 44
Co-Sponsors
Rep. F. Todd Polinchock
R House District 144
Rep. Carol Hill-Evans
D House District 95
Rep. R. Lee James
R House District 64
Rep. Stan Saylor
R House District 94
Rep. Dan Moul
R House District 91
Rep. David Zimmerman
R House District 99
Rep. Johnathan Hershey
R House District 82
Rep. Joe Ciresi
D House District 146
Rep. David Millard
R House District 109
Rep. Wendi Thomas
R House District 178
Bill Status & History
Last Action: Referred to Insurance, March 12, 2021
House
H
S
Printers Numbers
Votes
There are no votes available.
Committee Meetings
There are no committee meetings available.
Statute References
This bill amends the act of November 21, 2016 (P.L.1318, No.0169), known as the Pharmacy Audit Integrity And Transparency Act - Enactment. Other bills amending the same statute are listed below.
Only the first 5 bills are included here. Looking for more?
View all legislation amending the act of
November 21, 2016 (P.L.1318, No.0169), known as the Pharmacy Audit Integrity And Transparency Act - Enactment
House Bill 882
2021-2022 Regular Session
Sponsors
GAYDOS, POLINCHOCK, HILL-EVANS, JAMES, SAYLOR, MOUL, ZIMMERMAN, HERSHEY, CIRESI, MILLARD, THOMAS
Short Title
An Act amending the act of November 21, 2016 (P.L.1318, No.169), known as the Pharmacy Audit Integrity and Transparency Act, in pharmacy benefit manager cost transparency requirements, providing for sharing of cost, benefit and coverage data required.
Memo Subject
Prescription drug pricing transparency to reduce prescription abandonment
Actions
| 0871 | Referred to INSURANCE, March 12, 2021 |
Generated 09/26/2025 02:31 AM